HB1121 - CONCERNING COVERAGE FOR BIOMARKER TESTING FOR EARLY DETECTION AND MANAGEMENT FOR CANCER DIAGNOSES.
Bill Status History
Chamber
Date
Action
Vote
House
4/4/2023 9:59:58 AM
Notification that HB1121 is now Act 429
House
3/30/2023 9:19:59 AM
Correctly enrolled and ordered transmitted to the Governor's Office.
House
3/29/2023 5:35:01 PM
TO BE ENROLLED
House
3/29/2023 5:34:58 PM
Returned From the Senate as passed.
Senate
3/29/2023 4:09:43 PM
Returned to the House as passed.
Senate
3/28/2023 1:46:59 PM
Returned by the Committee, with the recommendation that it Do Pass
Senate
3/13/2023 4:44:35 PM
Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
Senate
3/13/2023 4:44:26 PM
Received from the House.
House
3/13/2023 1:53:36 PM
Read the third time and passed and ordered transmitted to the Senate.
House
3/8/2023 11:46:37 AM
Returned by the Committee Do Pass
House
2/28/2023 11:51:24 AM
REPORTED CORRECTLY ENGROSSED
House
2/28/2023 8:35:10 AM
Amendment No. 2 read and adopted and the bill ordered engrossed.
House
2/28/2023 8:35:08 AM
Placed on second reading for the purpose of amendment.
House
2/15/2023 10:35:03 AM
REPORTED CORRECTLY ENGROSSED
House
2/15/2023 8:35:38 AM
Amendment No. 1 read and adopted and the bill ordered engrossed.
House
2/15/2023 8:35:37 AM
Placed on second reading for the purpose of amendment.
House
1/12/2023 4:49:27 PM
Read the first time, rules suspended, read the second time and referred to the Committee on INSURANCE & COMMERCE- HOUSE
House
1/12/2023 11:11:31 AM
Filed
Amendments
Chamber
No.
Sponsor
Introduction Date
Document